• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT AUTOMATION SOLUTIONS GMBH TRACK SAMPLE MANAGER (TSM); CALCULATOR/ DATA PROCESSING MODULE, FOR CLINICAL USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT AUTOMATION SOLUTIONS GMBH TRACK SAMPLE MANAGER (TSM); CALCULATOR/ DATA PROCESSING MODULE, FOR CLINICAL USE Back to Search Results
Catalog Number 06Q29-01
Device Problem Delayed Program or Algorithm Execution (4034)
Patient Problem Insufficient Information (4580)
Event Date 07/11/2023
Event Type  Death  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
 
Event Description
The customer observed on (b)(6) 2023 the sample tubes were buffering in circles on the chain involving the glp track sample manager (tsm).The glims/re and re / tsm connections were active and the routine engine seemed to be working normally.The customer stopped, restarted tsm, and the system restarted.Additionally, the customer observed all the tubes would go to the buffer and the tsm no longer sent an in message to the re.The customer reported this incident seriously disrupted the activity, all the tubes were taken out of the chain, manually sorted, reloaded for re-analysis of the routes.The customer reported that the patient results were reported with a 2-3 hour delay to the physicians; however, the customer reported there was no impact to patients¿ treatment or medication.Additional information was provided on 19jul2023 that a 75-year-old male patient died that required a troponin and hemoglobin result to be analyzed; however, it is unclear if it was due to any delayed or missed treatment.No information was provided regarding the circumstances of the death.The customer reported the patient was followed by hemato-cancerology and the samples were collected at the home / outpatient.It is unknown what time the samples arrived at the lab.The following results were provided: troponin result was 47 pg/ml (released and transmitted at 6:00 p.M.).Hemoglobin result was 5.5 g/dl (transmitted at 7:00 p.M.).No further information has been provided.
 
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Additional information: this report is being filed on an international product, glp sample access line (sal), list number 06q27-01, which has a same/similar component of the modular glp systems track registered in the us, list number 04z96-51.Note: the glp systems track is not yet marketed in the u.S.
 
Event Description
The customer observed on 11jul2023 the sample tubes were buffering in circles on the chain involving the glp track sample manager (tsm).The glims/re and re/tsm connections were active and the routine engine seemed to be working normally.The customer stopped, restarted tsm, and the system restarted.Additionally, the customer observed all the tubes would go to the buffer and the tsm no longer sent an in message to the re.The customer reported this incident seriously disrupted the activity, all the tubes were taken out of the chain, manually sorted, reloaded for re-analysis of the routes.The customer reported that the patient results were reported with a 2-3 hour delay to the physicians; however, the customer reported there was no impact to patients¿ treatment or medication.Additional information was provided on 19jul2023 that a 75-year-old male patient died that required a troponin and hemoglobin result to be analyzed; however, it is unclear if it was due to any delayed or missed treatment.No information was provided regarding the circumstances of the death.The customer reported the patient was followed by hemato-cancerology and the samples were collected at the home/outpatient.It is unknown what time the samples arrived at the lab.The following results were provided: troponin result was 47 pg/ml (released and transmitted at 6:00 p.M).Hemoglobin result was 5.5 g/dl (transmitted at 7:00 p.M).No further information has been provided.
 
Manufacturer Narrative
The incident was reviewed which included the information provided in the complaint text and the track logs provided by the customer.The timeline within the logs was reviewed and found that the associated track sample manager (tsm) response times were within the recommended ranges.The investigation did note that no issues were observed and there was very low activity on the track.It was noted that the logs for the associated event were not provided and therefor unavailable to investigate.A review of tickets did not find any other complaints related to the current issue.Trending review did not identify any trends for the issue for the product.Labeling was reviewed and sufficiently addresses the customer's issue.Based on the investigation, no systemic issue or deficiency with the glp track sample manager was identified.All available patient information was included.Additional patient details are not available.
 
Event Description
The customer observed on (b)(6) 2023 the sample tubes were buffering in circles on the chain involving the glp track sample manager (tsm).The glims/re and re/tsm connections were active and the routine engine seemed to be working normally.The customer stopped, restarted tsm, and the system restarted.Additionally, the customer observed all the tubes would go to the buffer and the tsm no longer sent an in message to the re.The customer reported this incident seriously disrupted the activity, all the tubes were taken out of the chain, manually sorted, reloaded for re-analysis of the routes.The customer reported that the patient results were reported with a 2-3 hour delay to the physicians; however, the customer reported there was no impact to patients¿ treatment or medication.Additional information was provided on (b)(6) 2023 that a 75-year-old male patient died that required a troponin and hemoglobin result to be analyzed; however, it is unclear if it was due to any delayed or missed treatment.No information was provided regarding the circumstances of the death.The customer reported the patient was followed by hemato-cancerology and the samples were collected at the home/outpatient.It is unknown what time the samples arrived at the lab.The following results were provided: troponin result was 47 pg/ml (released and transmitted at 6:00 p.M.) hemoglobin result was 5.5 g/dl (transmitted at 7:00 p.M.) no further information has been provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRACK SAMPLE MANAGER (TSM)
Type of Device
CALCULATOR/ DATA PROCESSING MODULE, FOR CLINICAL USE
Manufacturer (Section D)
ABBOTT AUTOMATION SOLUTIONS GMBH
sachsenkamp 5
hamburg 20097
GM  20097
Manufacturer (Section G)
ABBOTT AUTOMATION SOLUTIONS GMBH
sachsenkamp 5
hamburg 20097
GM   20097
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key17496774
MDR Text Key320750451
Report Number3023268435-2023-00029
Device Sequence Number1
Product Code JQP
Combination Product (y/n)N
Reporter Country CodeLU
PMA/PMN Number
K213486
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 09/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number06Q29-01
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/10/2023
Initial Date FDA Received08/10/2023
Supplement Dates Manufacturer Received08/10/2023
09/01/2023
Supplement Dates FDA Received08/10/2023
09/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age75 YR
Patient SexMale
-
-